Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

The results below represent 576,025 women who should have had one or more cervical cancer screening tests during the previous 36 months or one cervical cancer screening test and a human papillomavirus test within the last 5 years. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
ThedaCare Physicians
87.33 %
View Historical Data
Prevea Health
86.29 %
View Historical Data
NOTE: Corrected results displaying effective 7/26/12
SSM Health Dean Medical Group
84.30 %
View Historical Data
Gundersen Health System
82.31 %
View Historical Data
Aurora Health Care Medical Group
82.08 %
View Historical Data
Marshfield Clinic
81.16 %
View Historical Data
Aurora UW Medical Group
81.14 %
View Historical Data
Bellin Medical Group
80.83 %
View Historical Data
ProHealth Medical Group
80.58 %
View Historical Data
UW Health Physicians
79.81 %
View Historical Data
Monroe Clinic
79.74 %
View Historical Data
Mercy Health
N=32705 n=23727
78.23 %
View Historical Data
Mayo Clinic Health System in Eau Claire
N=20004 n=13584
77.22 %
View Historical Data
Mayo Clinic Health System - Franciscan Healthcare
N=22517 n=17705
77.13 %
View Historical Data
Ascension | Columbia St. Mary's
N=45440 n=29131
71.41 %
View Historical Data
Ascension | Wheaton Franciscan Healthcare
N=38380 n=21675
60.53 %
View Historical Data
Aurora Advanced Healthcare

Did Not Report

There is good evidence that cervical cancer screening significantly reduces the incidence of and mortality from cervical cancer. The US Preventive Services Task Force suggests most of the benefit can be obtained by beginning screening at age 21. Recommendations include screening for women ages 21 through 64 with cytology (Pap smear) at least every 3 years and for women ages 30 through 64 who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years. An individuals specific clinical considerations, risk factors, etc. determine if testing is needed at a more frequent interval. It is recommended that women speak with their health care providers to determine the appropriate interval for their particular situation. There is limited evidence to determine the benefits of continued screening in women older than 65, due to declining incidence of high-grade cervical lesions after middle age. There is fair evidence that screening women older than 65 is associated with an increased risk for potential harm (US Preventive Services Task Force). Therefore, it is also recommended that women over age 65 speak with their health care providers to determine if continued screening is appropriate for their personal medical condition.

Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.